Screener
Prime Medicine PRME Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Prime Medicine in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: Prime Medicine’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:03 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053883
| (in thousands, except share and per share amounts) | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Research and development | 33,397 | 41,375 | 67,502 | 81,937 |
| General and administrative | 11,042 | 13,117 | 28,447 | 26,401 |
| Total operating expenses | 44,439 | 54,492 | 95,949 | 108,338 |
| Loss from operations | (43,285) | (53,377) | (93,939) | (105,769) |
| Other income: | ||||
| Interest income | 788 | 743 | 1,809 | 1,925 |
| Accretion (amortization) of investments | 333 | 530 | 793 | 869 |
| Change in fair value of short-term investment — related party | — | (505) | — | (1,561) |
Item 1. Financial Statements (unaudited)
FAQ
- What is Prime Medicine's operating income?
- Prime Medicine (PRME) reported operating income of -$43.29M in Q2 2026.
- How has Prime Medicine's operating income changed year-over-year?
- Prime Medicine's operating income increased by 18.9% year-over-year, from -$53.38M to -$43.29M.
- What is the long-term trend for Prime Medicine's operating income?
- Over 3 years (2022 to 2025), Prime Medicine's operating income has grown at a 21.4% compound annual growth rate (CAGR), from -$116.54M to -$208.35M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.
Ask your AI about Prime Medicine's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude